ASP Isotopes Inc. (NASDAQ: ASPI)

ASP Isotopes Inc. is an advanced materials company focused on developing and commercializing isotope enrichment technologies for nuclear medicine semiconductors and nuclear energy. The company’s core assets are its proprietary Aerodynamic Separation Process ASP and Quantum Enrichment QE platforms which enable production of enriched isotopes such as carbon 14 silicon 28 and ytterbium 176. In addition ASP Isotopes owns Renergen South Africa’s leading onshore natural gas explorer and the first integrated producer of liquid helium and liquefied natural gas LNG. Through subsidiaries PET Labs and East Coast Nuclear Pharmacy it participates in downstream radiopharmacy and through its ownership of Skyline it provides construction services in Hong Kong. The firm also pursues a nuclear fuels business via its subsidiary Quantum Leap Energy QLE to produce high assay low enriched uranium HALEU and lithium 6 for advanced reactors.

ASP Isotopes generates revenue primarily from the sale of enriched isotopes helium and LNG as well as from construction contracts and licensing royalties. The company has secured tolling and purchase agreements for its future isotope output including a multi year take or pay contract with a Canadian customer for carbon 14 and purchase orders from a U S semiconductor company and a global industrial gas company for silicon 28. Renergen contributes revenue through domestic LNG sales in South Africa and planned exports of high purity helium to global markets facing supply shortages. Skyline’s construction arm earns fees from civil engineering projects such as road and drainage works in Hong Kong. ASP Isotopes also receives a perpetual royalty equal to 10 % of future QLE revenues under a license agreement that grants QLE the right to use ASP and QE technologies for uranium and lithium 6 enrichment.

The company operates through three reportable segments nuclear fuels specialist isotopes and related services and construction services.

• Nuclear Fuels: This segment is focused on research and development of technologies and methods to produce high assay low enriched uranium HALEU and lithium 6 for advanced nuclear reactors including small modular reactors. It encompasses the activities of Quantum Leap Energy its partnerships with TerraPower and NECSA and the pursuit of uranium enrichment projects in South Africa the United States and the United Kingdom.

• Specialist Isotopes and Related Services: This segment concentrates on the development and commercialization of high value low volume isotopes such as carbon 14 silicon 28 and ytterbium 176 for markets including pharmaceuticals agrochemicals nuclear medical imaging and semiconductors. It includes the ASP and QE enrichment facilities in Pretoria the downstream radiopharmacy operations of PET Labs and East Coast Nuclear Pharmacy and related technical services.

• Construction Services: This segment provides public civil engineering works in Hong Kong chiefly road and drainage projects through Skyline’s wholly owned subsidiaries Kin Chiu Engineering Limited and Kin Chiu Development Company Limited. Activities involve site clearance concrete installation excavation fill compaction and landscaping.

ASP Isotopes holds a differentiated position in the isotope enrichment industry due to its low cost modular ASP and QE technologies which enable efficient separation of light isotopes where traditional centrifuges are less effective. The company faces competition from established biotech and nuclear medicine firms for medical isotopes and from other enrichment enterprises for uranium but it benefits from proprietary know‑how lower capital expenditures and the ability to site facilities near end users. In the helium and LNG markets Renergen enjoys a near monopoly as South Africa’s sole domestic LNG producer and exploits a helium concentration above 3 % far exceeding typical global averages giving it a cost advantage over overseas suppliers. In construction Skyline competes with local contractors but gains access to projects through its parent’s relationships and its status as an approved main contractor.

The company’s customer base includes a Canadian off taker for carbon 14 a U S semiconductor company and a global industrial gas company for silicon 28 and TerraPower as a prospective buyer of HALEU. Renergen sells LNG to domestic South African utilities and industrial users and intends to export helium to international customers in the semiconductor aerospace and medical imaging sectors. Skyline serves property developers government agencies and infrastructure firms in Hong Kong that require civil engineering works. Additionally ASP Isotopes supplies radiopharmaceuticals to hospitals and clinics through its PET Labs and East Coast Nuclear Pharmacy subsidiaries.